Example: Heart Attack

Clinical Trials Sponsored by Innovive Pharmaceuticals

Total 3 results

NCT00255333

Terminated

INNO-105 in Patients With Solid Tumors

Conditions: Tumors
NCT00665002

Completed

Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms

Conditions: Leukemia
NCT00398138

Completed

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Conditions: Leukemia; Lung Cancer; Malignant Mesothelioma; Myelodysplastic Syndromes; Primary Peritoneal Cavity Cancer